Pyxis Oncology Names Alex Kane as Senior Vice President of Investor Relations and Capital Markets
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 08 2025
0mins
Source: Globenewswire
New Appointment: Pyxis Oncology has appointed Alex Kane as Senior Vice President of Investor Relations & Capital Markets, effective immediately, bringing 20 years of experience in the life sciences sector.
Expertise and Background: Kane previously worked at Guggenheim Securities and held senior roles at Praxis Precision Medicines and PTC Therapeutics, focusing on investor relations and capital markets strategies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
